Could a mushroom extract boost lung cancer treatment?

NCT ID NCT07197853

Not yet recruiting Disease control Sponsor: Xin Ye Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether adding Huaier granules (a traditional Chinese medicine) to microwave ablation improves outcomes for people with stage IA non-small cell lung cancer who cannot have surgery. 180 participants will be randomly assigned to receive ablation alone or ablation plus Huaier granules for 72 weeks. The study will measure progression-free survival, tumor control, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Huaier granules (a traditional Chinese medicine extract) and microwave ablation
What this could lead to: If successful, this combination could offer a more effective treatment option for people with early-stage lung cancer who cannot have surgery, potentially improving tumor control and survival.
What could go wrong: This is a single-center trial, so results may not apply broadly. The addition of Huaier granules may not provide significant benefit over ablation alone, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUAIER GRANULES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HUAIER GRANULES MICROWAVE ABLATION NON-SMALL CELL LUNG CANCER (NSCLC)

More trials for these conditions

Other studies related to the condition(s) this trial covers.